drugset / Trial / NCT04343001
Coronavirus Response - Active Support for Hospitalised Covid-19 Patients
RandomizedFactorialOpen-labelTreatment
Summary
The CRASH-19 trial is a multinational, open-label, factorial, randomised trial in adults hospitalised with suspected or confirmed acute COVID-19 infection.
Timeline
- Start
- 2020-10
- Primary completion
- 2021-04
- Completion
- 2021-08
Outcome
Outcome not reported
Stopped: “Grant not obtained”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 150 mg | — |
| Subject | Losartan | Other / unclassified | 100 mg | — |
| Subject | Simvastatin | Small molecule | 80 mg | — |